Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Verses AI Inc N.VERS

Alternate Symbol(s):  VRSSF | N.VERS.WT.A | N.VERS.WT.B

VERSES AI Inc. is a Canada-based cognitive computing company specializing in intelligence software systems. The Company is primarily focused on developing an intelligence-as-a-service smart software platform, Genius, through its subsidiary VERSES Technologies USA Inc. (VTU). Its flagship product, Genius, is a toolkit for developers to generate intelligent software agents that enhance existing... see more

NEO:VERS - Post Discussion

Verses AI Inc > VERS.n with a strong close to the week up 15% returning to t
View:
Post by stockpatrol on Dec 09, 2022 6:49pm

VERS.n with a strong close to the week up 15% returning to t

VERS.n with a strong close to the week up 15% returning to the $.70 range. 
 
https://twitter.com/search?q=%24vers.n&src=typed_query&f=live
 
I think we are at the beginning of seeing how the latest deal with Blue Yonder will effect the company. Blue Yonders a great sign of validation, reselling VERS.n's tech to their client base only reinforces that confidence. Looking forward to how this plays out next week
Be the first to comment on this post